Trial Profile
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Samarium 153 lexidronam (Primary) ; Calcium; Strontium-89; Vitamin D analogues; Zoledronic acid
- Indications Advanced breast cancer; Bone metastases; Lung cancer; Prostate cancer
- Focus Registrational; Therapeutic Use
- 03 Apr 2018 Status changed from active, no longer recruiting to completed.
- 01 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jun 2009 Additional lead trial investigators identified as reported by New Jersey Cancer Trial Connect.